A Review on Valeriana wallichii: Chemical Composition and Pharmacological
Research

Ghosia      Jamal; Rabea      Parveen; Mohammad   Aasif   Khan; Varsha      Srivastava; Saad      Mustafa; Sayeed      Ahmad; Syed   Akhtar   Husain
Abstract

Background: In the past decade, a rising trend has been seen in the use of plant-based medicines because of fewer/no side effects. Plants are always the major source of traditional medicines in every culture. The main objective of this review is to shed light on the phytochemical composition and pharmacological research of Valeriana wallichii.
Methods: Electronic databases like Google Scholar, PubMed, Scopus, etc., were searched for traditional uses, extraction of phytoconstituents, therapeutical uses and pharmacology of V. wallichii.
Results: V. wallichii has been used as a sleep remedy since ancient times in the Indian traditional system of medicines. It is also used as a diuretic, spasmolytic and pain-relieving agent. It is used for the treatment of epilepsy, dyspeptic symptoms, failing reflexes, habitual constipation, insanity, nervous debility, obesity, spastic disorders, and in snake poisoning, and also reported to have cytotoxic potential. The pharmacological activity of the plant is due to the presence of different types of secondary metabolites, including valerianic acid, valerosidatum glycoside, valepotriates, dihydrovaltrate, 6-methylapigenin, hesperidin, sesquiterpenoids, bornylisovalerianate, isovalerenic acid, 1-camphene, 1-pinene, terpineol, valerianine, bornylisovalerianate, valerianine and so on. This review focuses on the detailed phytochemistry of the plant and its therapeutic indication. The main emphasis is given to the anticancer potential of V. wallichii, with in vitro cytotoxic as well as in vivo antitumor description.
Conclusion: The review reveals that further research, as well as clinical trials, are needed to know this plant as an effective drug for the treatment of cancer in the future with exact molecular mechanisms.
Keywords: Valeriana wallichii DC., Valerianaceae, Indian Valerian, Valepotriates, Pharmacological activity.
Graphical Abstract

[1]
Nandhini S, Narayanan KB, Ilango K. Valeriana officinalis: A review of its traditional uses, phytochemistry and pharmacology. Asian J Pharm Clin Res  2018; 11(1): 36.
 [http://dx.doi.org/10.22159/ajpcr.2018.v11i1.22588]

[2]
Muthukrishnan S, Palanisamy S, Subramanian S, Selvaraj S, Mari KR, Kuppulingam R. Phytochemical profile of Erythrina variegata by using high-performance liquid chromatography and gas chromatography-mass spectroscopy analyses. JAMS J Acupunct Meridian Stud 2016.
 [http://dx.doi.org/10.1016/j.jams.2016.06.001]

[3]
WHO. WHO monographs on selected medicinal plants. Essent Med Heal Prod Inf Portal 1999.

[4]
Sarker SD, Nahar L. An introduction to natural products isolation. Methods Mol Biol  2012; 864: 1-25.
 [http://dx.doi.org/10.1007/978-1-61779-624-1_1] [PMID:  22367891]

[5]
Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod  2016; 79(3): 629-61.
 [http://dx.doi.org/10.1021/acs.jnatprod.5b01055] [PMID:  26852623]

[6]
Heinrich M. Ethnobotany and its role in drug development. Phytother Res  2000; 14(7): 479-88.
 [http://dx.doi.org/10.1002/1099-1573(200011)14:7<479::AIDPTR958>3.0.CO;2-2] [PMID:  11054835]

[7]
World Health Organization. WHO monograph volume 2. Africa (Lond) 2002.

[8]
Shakya AK. Medicinal plants: Future source of new drugs. Int J Herb Med  2016; 4(4): 59-64.

[9]
Khan MA, Srivastava V, Kabir M, et al. Development of synergy-based combination for learning and memory using in vitro, in vivo and TLC-MS-bioautographic studies. Front Pharmacol  2021; 12: 678611.
 [http://dx.doi.org/10.3389/fphar.2021.678611] [PMID:  34276370]

[10]
Verma P, Mathur AK, Jain SP, Mathur A. In vitro conservation of twenty-three overexploited medicinal plants belonging to the Indian sub continent. ScientificWorldJ  2012; 2012: 929650.
 [http://dx.doi.org/10.1100/2012/929650] [PMID:  22593711]

[11]
Hullatti K, Pathade N, Mandavkar Y, Godavarthi A, Biradi M. Bioactivity-guided isolation of cytotoxic constituents from three medicinal plants. Pharm Biol  2013; 51(5): 601-6.
 [http://dx.doi.org/10.3109/13880209.2012.753919] [PMID:  23363069]

[12]
Houghton PJ. The scientific basis for the reputed activity of valerian. J Pharm Pharmacol  2010; 51(5): 505-12.
 [http://dx.doi.org/10.1211/0022357991772772] [PMID:  10411208]

[13]
Sharma M, Jain UK, Patel A, Gupta N, Vidyanagar S, Road B. A comprehensive pharmacognostic report on valerian. Int J Pharm Sci Res  2010; 2: 6-40.

[14]
Lefebvre T, Foster BC, Drouin CE, Krantis A, Livesey JF, Jordan SA. In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4. J Pharm Pharm Sci  2004; 7(2): 265-73.
 [PMID:  15367385]

[15]
Ghosh S, Debnath S, Hazra S, et al. Valeriana wallichii root extracts and fractions with activity against Leishmania spp. Parasitol Res  2011; 108(4): 861-71.
 [http://dx.doi.org/10.1007/s00436-010-2127-0] [PMID:  21085992]

[16]
Dweck AC. An introduction to valerian Valeriana officinalis and related species. In: Houghton PJ, Ed. Valerian: The Genus Valeriana. London, UK: Routledge 2017.
 [http://dx.doi.org/10.1201/9780203734483-1]

[17]
Woerdenbag HJ, Bos R, Scheffer JJC. Valerian: Quality assurance of the crude drug and its preparations. In: Houghton PJ, Ed. Valerian: The Genus Valeriana. London, UK: Routledge 2017.

[18]
Das G, Shin HS, Tundis R, et al. Plant species of sub-family valerianaceae-a review on its effect on the central nervous system. Plants  2021; 10(5): 846.
 [http://dx.doi.org/10.3390/plants10050846] [PMID:  33922184]

[19]
Sah SP, Mathela CS, Chopra K. Antidepressant effect of Valeriana wallichii patchouli alcohol chemotype in mice: Behavioural and biochemical evidence. J Ethnopharmacol  2011; 135(1): 197-200.
 [http://dx.doi.org/10.1016/j.jep.2011.02.018] [PMID:  21354297]

[20]
Mulliken T, Crofton P. Review of the status, harvest, trade and management of seven Asian CITES-listed medicinal and aromatic plant species. Federal Agency for Natural 2008.

[21]
Sánchez M, Burgos EG, Iglesias I, Pilar Gómez-Serranillos M. Updating the biological interest of Valeriana officinalis. Mediterr Bot  2021; 42: e70280.
 [http://dx.doi.org/10.5209/mbot.70280]

[22]
Alfaro-Romero A, Balderas-López JL, Tavares-Carvalho JC, Navarrete A. Valeiridoside, an iridoid xyloside from Valeriana procera with anxiogenic effect in mice. Rev Bras Farmacogn  2021; 31(1): 85-90.
 [http://dx.doi.org/10.1007/s43450-021-00140-x]

[23]
Ascate-Pasos ME, Ganozayupanqui ML, Suárez-Rebaza LA, Bussmann RW. Valeriana pilosa ruiz & pav.: A review of traditional uses, phytochemistry and pharmacology. Ethnobot Res Appl  2020; 20: 1-15.
 [http://dx.doi.org/10.32859/era.20.19.1-15]

[24]
Hölzl J. The pharmacology and therapeutics of valeriana. In: Houghton PJ, Ed. Valerian: The Genus Valeriana. London, UK: Routledge 2017.
 [http://dx.doi.org/10.1201/9780203734483-3]

[25]
Khuda F, Iqbal Z, Khan A, Nasir F, Shah Y. Anti-inflammatory activity of the topical preparation of Valeriana wallichii and Achyranthes aspera leaves. Pak J Pharm Sci  2013; 26(3): 451-4.

[26]
Xu J, Guo Y, Jin DQ, et al. Three new iridoids from the roots of Valeriana jatamansi. J Nat Med  2012; 66(4): 653-7.
 [http://dx.doi.org/10.1007/s11418-012-0631-5] [PMID:  22331424]

[27]
Sundaresan N, Ilango K. Review on Valeriana species-Valeriana wallichii and Valeriana jatamansi. J Pharm Sci Res  2018; 10(11): 2697-701.

[28]
Kurmukov AG. Phytochemistry of medicinal plants. In: Eisenman SW, Zaurov DE, Struwe L, Eds. Medicinal Plants of Central Asia: Uzbekistan and Kyrgyzstan.  New York, NY: Springer 2013; pp. 13-4.
 [http://dx.doi.org/10.1007/978-1-4614-3912-7_4]

[29]
Devi VS, Rao MG, Maheswari MU. Preliminary phytochemical screening of various extracts of Valeriana wallichii root. Sky J Biochem Res  2014; 3(9): 80-5.

[30]
Wadood A, Ghufran M, Jamal SB, et al. Phytochemical analysis of medicinal plants occurring in local area of Mardan. Biochem Anal Biochem  2013; 2(4): 1-4.
 [http://dx.doi.org/10.4172/2161-1009.1000144]

[31]
Mathela CS, Tiwari M, Sammal SS, Chanotiya CS. Valeriana wallichii DC, a new chemotype from northwestern himalaya. J Essent Oil Res  2005; 17(6): 672-5.
 [http://dx.doi.org/10.1080/10412905.2005.9699029]

[32]
Parveen Z, Siddique S, Shafique M, Khan SJ, Khanum R. Study of chemical and biological aspects of Valeriana wallichii DC. Root essential oil. Asian J Chem  2012; 24(7): 3243-6.

[33]
Sacchetti G, Maietti S, Muzzoli M, et al. Comparative evaluation of 11 essential oils of different origin as functional antioxidants, antiradicals and antimicrobials in foods. Food Chem  2005; 91(4): 621-32.
 [http://dx.doi.org/10.1016/j.foodchem.2004.06.031]

[34]
Lin S, Zhang ZX, Chen T, et al. Characterization of chlorinated valepotriates from Valeriana jatamansi. Phytochemistry  2013; 85: 185-93.
 [http://dx.doi.org/10.1016/j.phytochem.2012.08.015] [PMID:  23036722]

[35]
Marder M, Viola H, Wasowski C, Fernández S, Medina JH, Paladini AC. 6-methylapigenin and hesperidin: New Valeriana flavonoids with activity on the CNS. Pharmacol Biochem Behav  2003; 75(3): 537-45.
 [http://dx.doi.org/10.1016/S0091-3057(03)00121-7] [PMID:  12895671]

[36]
Wills RBH, Bone K, Morgan M. Herbal products: Active constituents, modes of action and quality control. Nutr Res Rev  2000; 13(1): 47-77.
 [http://dx.doi.org/10.1079/095442200108729007] [PMID:  19087433]

[37]
Cropley M, Cave Z, Ellis J, Middleton RW. Effect of kava and valerian on human physiological and psychological responses to mental stress assessed under laboratory conditions.  Phyther Res  2002; 16(1): 23-7.
 [http://dx.doi.org/10.1002/ptr.1002]

[38]
Wang R, Xiao D, Bian YH, et al. Minor iridoids from the roots of Valeriana wallichii. J Nat Prod  2008; 71(7): 1254-7.
 [http://dx.doi.org/10.1021/np070598p] [PMID:  18557641]

[39]
Joseph L, Puthallath RE, Rao SN. Acute and chronic toxicity study of Valeriana wallichii rhizome hydro-ethanolic extract in Swiss albino mice. Asian J Med Sci  2015; 7(2): 49-54.
 [http://dx.doi.org/10.3126/ajms.v7i2.13326]

[40]
Liu XC, Zhou L, Liu ZL. Identification of insecticidal constituents from the essential oil of Valeriana jatamansi Jones against Liposcelis bostrychophila Badonnel. J Chem  2013; 2013: 1-6.
 [http://dx.doi.org/10.1155/2013/853912]

[41]
Sen-Utsukarci B, Kessler SM, Akbal-Dagistan O, et al. Chemical composition and biological activities of Valeriana dioscoridis SM. Roots. S Afr J Bot  2021; 141: 306-12.
 [http://dx.doi.org/10.1016/j.sajb.2021.05.007]

[42]
Zhang N-N, Ding G-Z. Development and research advances of iridoids from Valeriana jatamansi and their bioactivity. Zhongguo Zhongyao zazhi  2015; 40(10): 1893-7.

[43]
Chen HW, Wei BJ, He XH, Liu Y, Wang J. Chemical components and cardiovascular activities of Valeriana spp. Evid Based Complement Alternat Med  2015; 2015: 947619.
 [http://dx.doi.org/10.1155/2015/947619] [PMID:  26788113]

[44]
Cos P, Vlietinck AJ, Berghe DV, Maes L. Anti-infective potential of natural products: How to develop a stronger in vitro ‘proof-of-concept’. J Ethnopharmacol  2006; 106(3): 290-302.
 [http://dx.doi.org/10.1016/j.jep.2006.04.003] [PMID:  16698208]

[45]
Sasidharan S, Chen Y, Saravanan D, Sundram KM, Yoga Latha L. Extraction, isolation and characterization of bioactive compounds from plants’ extracts. Afr J Tradit Complement Altern Med  2011; 8(1): 1-10.
 [PMID:  22238476]

[46]
Dhiman B, Sharma P. Shivani, Pal PK. Biology, chemical diversity, agronomy, conservation and industrial importance of Valeriana jatamansi: A natural sedative. J Appl Res Med Aromat Plants  2020; 16: 100243.
 [http://dx.doi.org/10.1016/j.jarmap.2020.100243]

[47]
Fernández S, Wasowski C, Paladini AC, Marder M. Sedative and sleep-enhancing properties of linarin, a flavonoid-isolated from Valeriana officinalis. Pharmacol Biochem Behav  2004; 77(2): 399-404.
 [http://dx.doi.org/10.1016/j.pbb.2003.12.003] [PMID:  14751470]

[48]
Hattesohl M, Feistel B, Sievers H, Lehnfeld R, Hegger M, Winterhoff H. Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties. Phytomedicine  2008; 15(1-2): 2-15.
 [http://dx.doi.org/10.1016/j.phymed.2007.11.027] [PMID:  18160026]

[49]
Sah SP, Mathela CS, Chopra K. Involvement of nitric oxide (NO) signalling pathway in the antidepressant activity of essential oil of Valeriana wallichii Patchouli alcohol chemotype. Phytomedicine  2011; 18(14): 1269-75.
 [http://dx.doi.org/10.1016/j.phymed.2011.06.009] [PMID:  21795033]

[50]
Jugran AK, Rawat S, Bhatt ID, Rawal RS. Valeriana jatamansi: An herbaceous plant with multiple medicinal uses. Phytother Res  2019; 33(3): 482-503.
 [http://dx.doi.org/10.1002/ptr.6245] [PMID:  30663144]

[51]
Patocka J, Jakl J. Biomedically relevant chemical constituents of Valeriana officinalis. J Appl Biomed  2010; 8(1): 11-8.

[52]
Maurya AK, Sharma A, Kumar K, et al. Comparative studies of essential oils composition and cytotoxic activity of Valeriana jatamansi Jones. J Essent Oil Res  2021; 33(6): 584-91.
 [http://dx.doi.org/10.1080/10412905.2021.1966846]

[53]
Wang Y, Shi DQ, Jiang N, et al. A new acylated iridoid and other chemical constituents from Valeriana jatamansi and their biological activities. Nat Prod Res  2021; 1-8.
 [http://dx.doi.org/10.1080/14786419.2021.1961255] [PMID:  34343061]

[54]
Wang H, Song Z, Xing H, et al. Nitric oxide inhibitory iridoids as potential anti-inflammatory agents from Valeriana jatamansi. Bioorg Chem  2020; 101: 103974.
 [http://dx.doi.org/10.1016/j.bioorg.2020.103974] [PMID:  32512268]

[55]
Eftekhari Z. Antimicrobial properties of medicinal plants; The new therapeutic aspect of Valeriana officinalis. Plant Biotechnol Persa  2020; 2(1): 59-60.
 [http://dx.doi.org/10.29252/pbp.2.1.59]

[56]
Rondón M, Velasco J, Rojas J, Gámez L, León G, Entralgo E, et al. Antimicrobial activity of four Valeriana (Caprifoliaceae) species endemic to the Venezuelan Andes. Rev Biol Trop  2018; 66(3): 1282-9.
 [http://dx.doi.org/10.15517/rbt.v66i3.30699]

[57]
Syed S. Antioxidant and hepatoprotective activity of ethanol extract of Valeriana wallichii in CCl4 treated rats. Br J Pharm Res  2014; 4(8): 1004-13.
 [http://dx.doi.org/10.9734/BJPR/2014/7378]

[58]
Gilani AH, Mandukhail SUR, Iqbal J, et al. Antispasmodic and vasodilator activities of Morinda citrifolia root extract are mediated through blockade of voltage dependent calcium channels. BMC Complement Altern Med  2010; 10(1): 2.
 [http://dx.doi.org/10.1186/1472-6882-10-2] [PMID:  20070879]

[59]
Sudati JH, Fachinetto R, Pereira RP, et al. In vitro antioxidant activity of Valeriana officinalis against different neurotoxic agents. Neurochem Res  2009; 34(8): 1372-9.
 [http://dx.doi.org/10.1007/s11064-009-9917-8] [PMID:  19191025]

[60]
Ota M, Ni H, Maki Y, et al. Binding activity of Valeriana fauriei root extract on GABAA receptor flunitrazepam sites and distribution of its active ingredients in the brain of mice - A comparison with that of V. officinalis root. J Ethnopharmacol  2021; 278: 114262.
 [http://dx.doi.org/10.1016/j.jep.2021.114262] [PMID:  34116188]

[61]
Sahu S, Ray K, Yogendra Kumar MS, et al. Valeriana wallichii root extract improves sleep quality and modulates brain monoamine level in rats. Phytomedicine  2012; 19(10): 924-9.
 [http://dx.doi.org/10.1016/j.phymed.2012.05.005] [PMID:  22766307]

[62]
Al-Attraqchi OHA, Deb PK, Al-Attraqchi NHA. Review of the phytochemistry and pharmacological properties of Valeriana officinalis. Curr Tradit Med  2020; 6(4): 260-77.

[63]
Glaser J, Schultheis M, Moll H, Hazra B, Holzgrabe U. Antileishmanial and cytotoxic compounds from Valeriana wallichii and identification of a novel nepetolactone derivative. Molecules  2015; 20(4): 5740-53.
 [http://dx.doi.org/10.3390/molecules20045740] [PMID:  25834987]

[64]
Masic A, Valencia Hernandez AM, Hazra S, et al. Cinnamic acid bornyl ester derivatives from Valeriana wallichii exhibit antileishmanial in vivo activity in Leishmania major-infected BALB/c Mice. PLoS One  2015; 10(11): e0142386.
 [http://dx.doi.org/10.1371/journal.pone.0142386] [PMID:  26554591]

[65]
Xu J, Yang B, Guo Y, et al. Neuroprotective bakkenolides from the roots of Valeriana jatamansi. Fitoterapia  2011; 82(6): 849-53.
 [http://dx.doi.org/10.1016/j.fitote.2011.04.012] [PMID:  21596109]

[66]
Tan YZ, Yong Y, Dong YH, et al. A new secoiridoid glycoside and a new sesquiterpenoid glycoside from Valeriana jatamansi with neuroprotective activity. Phytochem Lett  2016; 17: 177-80.
 [http://dx.doi.org/10.1016/j.phytol.2016.07.020]

[67]
Khan AU, Gilani AH. Antidiarrhoeal and bronchodilatory potential of Valeriana wallichii. Nat Prod Res  2012; 26(11): 1045-9.
 [http://dx.doi.org/10.1080/14786419.2010.551754] [PMID:  22010976]

[68]
Orhan IE. A review focused on molecular mechanisms of anxiolytic effect of Valerina officinalis L. in connection with its phytochemistry through in vitro/in vivo studies. Curr Pharm Des  2021; 27(28): 3084-90.
 [http://dx.doi.org/10.2174/1381612827666210119105254] [PMID:  33463459]

[69]
Wang SN, Yao ZW, Zhao CB, et al. Discovery and proteomics analysis of effective compounds in Valeriana jatamansi jones for the treatment of anxiety. J Ethnopharmacol  2021; 265: 113452.
 [http://dx.doi.org/10.1016/j.jep.2020.113452] [PMID:  33069789]

[70]
Mehvish S, Barkat MQ. Phytochemical and antioxidant screening of Amomum subulatum, Elettaria cardamomum, Emblica officinalis, Rosa damascene, Santalum album and Valeriana officinalis and their effect on stomach, liver and heart. Matrix Sci Medica  2018; 2(2): 28-33.

[71]
Benke D, Barberis A, Kopp S, et al. GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of Valerian root extracts. Neuropharmacology  2009; 56(1): 174-81.
 [http://dx.doi.org/10.1016/j.neuropharm.2008.06.013] [PMID:  18602406]

[72]
Bruni O, Ferini-Strambi L, Giacomoni E, Pellegrino P. Herbal remedies and their possible effect on the gabaergic system and sleep. Nutrients  2021; 13(2): 530.
 [http://dx.doi.org/10.3390/nu13020530] [PMID:  33561990]

[73]
Wasowski C, Marder M, Viola H, Medina JH, Paladini AC. Isolation and identification of 6-methylapigenin, a competitive ligand for the brain GABA(A) receptors, from Valeriana wallichii. Planta Med  2002; 68(10): 934-6.
 [http://dx.doi.org/10.1055/s-2002-34936] [PMID:  12391561]

[74]
Gilani AH, Khan AU, Jabeen Q, Subhan F, Ghafar R. Antispasmodic and blood pressure lowering effects of Valeriana wallichii are mediated through K+ channel activation. J Ethnopharmacol  2005; 100(3): 347-52.
 [http://dx.doi.org/10.1016/j.jep.2005.05.010] [PMID:  16002246]

[75]
Sah SP, Mathela CS, Chopra K. Elucidation of possible mechanism of analgesic action of Valeriana wallichii DC chemotype (patchouli alcohol) in experimental animal models. Indian J Exp Biol  2010; 48(3): 289-93.
 [PMID:  21046983]

[76]
Of E, Wallichii V, Rhizome DC. Anti-inflammatory activity of methanolic and aqueous extracts of Valeriana wallichii rhizome. Analysis  2007; 13(2): 103-8.

[77]
Phytochemical Aspects of Indian Valerian. “Tagara” (Valeriana wallichii) from Uttarakhand, Western Himalaya. In: Univ J Phytochem Ayurvedic Height.  2020.

[78]
Sharma N, Bahuguna V, Rawat R, Lalremruati F, Singh A. Complete plant regeneration of Valeriana wallichii DC. On auxin enriched medium and phytochemical analysis. Plant Sci Today  2020; 7(4): 542-50.
 [http://dx.doi.org/10.14719/pst.2020.7.4.837]

[79]
Moy TI, Ball AR, Anklesaria Z, Casadei G, Lewis K, Ausubel FM. Identification of novel antimicrobials using a live-animal infection model. Proc Natl Acad Sci USA  2006; 103(27): 10414-9.
 [http://dx.doi.org/10.1073/pnas.0604055103] [PMID:  16801562]

[80]
Letchamo W, Ward W, Heard B, Heard D. Essential oil of Valeriana officinalis L. cultivars and their antimicrobial activity as influenced by harvesting time under commercial organic cultivation. J Agric Food Chem  2004; 52(12): 3915-9.
 [http://dx.doi.org/10.1021/jf0353990] [PMID:  15186117]

[81]
Sati SC, Khulbe K. Antibacterial evaluation of the Himalayan medicinal plant Valeriana wallichii DC. (Valerianaceae). Res J Microbiol  2011; 6: 289-96.

[82]
Laxane SN, Swarnkar SK, Setty MM. Antioxidant studies on the ethanolic extract of Zornia gibbosa. Pharmacologyonline  2008; 1(1): 319-30.

[83]
Youdim KA, Damien Dorman HJ, Deans SG. The antioxidant effectiveness of thyme oil, α-tocopherol and ascorbyl palmitate on evening primrose oil oxidation. J Essent Oil Res  1999; 11(5): 643-8.
 [http://dx.doi.org/10.1080/10412905.1999.9701231]

[84]
Kalim MD, Dutta D, Das P, Chattopadhyay S. Evaluation of phytochemicals interrelated to antioxidant potential of Unani plants. Int J Pharma Bio Sci  2015; 6(3): 330-42.

[85]
Zhang L, Wang L, Huang L, et al. Antidepressant effects of total iridoids of Valeriana jatamansi via the intestinal flora-blood-brain barrier pathway. Pharm Biol  2021; 59(1): 912-21.
 [http://dx.doi.org/10.1080/13880209.2021.1944222] [PMID:  34236293]

[86]
Yang S, Chen F, Ma H, Wang T. Protection of Valeriana officinalis L. extract preconditioning on ischemia-reperfusion injury in rat hearts in vitro. Wuhan Daxue Xuebao Yixue Ban  2012; 33(5): 639-43.

[87]
Liu X, Duan X, Fan H, et al. 8-Hydroxypinoresinol-4-O-β-D-glucoside from Valeriana officinalis L. Is a Novel Kv1.5 channel blocker. J Ethnopharmacol  2021; 279: 114442.
 [http://dx.doi.org/10.1016/j.jep.2021.114442]

[88]
Bhokare DSD, Jadhav DSK. Conceptual study of anti-toxic action of tagaradi agada on poisonous insects bite: A short review. Int J Res -Granthaalayah  2020; 8(4): 99-103.

[89]
Pakseresht S, Boostani H, Sayyah M. Extract of valerian root (Valeriana officinalis L.) vs. placebo in treatment of obsessivecompulsive disorder: A randomized double-blind study. J Complement Integr Med  2011; 8(1): 1553-3840. 1465/1553-3840.14.
 [http://dx.doi.org/10.2202/1553-3840.1465] [PMID: 22718671]

[90]
Tzakou O, Couladis M, Pavlovic M, Agarwal PC. Composition and antifungal activity of the oil from aerial parts and rhizomes of Valeriana dioscoridis from Greece. J Essent Oil Res  2004; 16(5): 500-3.
 [http://dx.doi.org/10.1080/10412905.2004.9698781]

[91]
Berridge CW. Noradrenergic modulation of arousal. Brain Res Brain Res Rev  2008; 58(1): 1-17.
 [http://dx.doi.org/10.1016/j.brainresrev.2007.10.013] [PMID:  18199483]

[92]
Mitchell HA, Weinshenker D. Good night and good luck: Norepinephrine in sleep pharmacology. Biochem Pharmacol  2010; 79(6): 801-9.
 [http://dx.doi.org/10.1016/j.bcp.2009.10.004] [PMID:  19833104]

[93]
Leu-Semenescu S, Arnulf I, Decaix C, et al. Sleep and rhythm consequences of a genetically induced loss of serotonin. Sleep  2010; 33(3): 307-14.
 [http://dx.doi.org/10.1093/sleep/33.3.307] [PMID:  20337188]

[94]
Monti B, Polazzi E, Contestabile A. Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr Mol Pharmacol  2009; 2(1): 95-109.
 [PMID:  20021450]

[95]
Roth T. Insomnia: Definition, prevalence, etiology, and consequences. J Clin Sleep Med  2007; 3(5) (Suppl.): S7-S10.
 [PMID:  17824495]

[96]
Riemann D, Voderholzer U. Primary insomnia: A risk factor to develop depression? J Affect Disord  2003; 76(1-3): 255-9.
 [http://dx.doi.org/10.1016/S0165-0327(02)00072-1] [PMID:  12943956]

[97]
Toolika E, Bhat NP, Shetty SK. A comparative clinical study on the effect of Tagara (Valeriana wallichii DC.) and Jatamansi (Nardostachys jatamansi DC.) in the management of Anidra (primary insomnia). Ayu  2015; 36(1): 46-9.
 [http://dx.doi.org/10.4103/0974-8520.169008] [PMID:  26730138]

[98]
Estrada-Soto S, Rivera-Leyva J, Ramírez-Espinosa JJ, Castillo-España P, Aguirre-Crespo F, Hernández-Abreu O. Vasorelaxant effect of Valeriana edulis ssp. procera (Valerianaceae) and its mode of action as calcium channel blocker. J Pharm Pharmacol  2010; 62(9): 1167-74.
 [http://dx.doi.org/10.1111/j.2042-7158.2010.01146.x] [PMID:  20796196]

[99]
Hypertension and herbal plants. Int Res J Pharm (Cairo) 2011.

[100]
Anchala R, Kannuri NK, Pant H, et al. Hypertension in India: A systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens  2014; 32(6): 1170-7.
 [http://dx.doi.org/10.1097/HJH.0000000000000146] [PMID:  24621804]

[101]
Ahmed A, Saqlain M, Tanveer M, et al. Prescribing patterns of antihypertensive drugs in patients attending Tertiary Care Hospitals in Pakistan. SN Compr Clin Med  2021; 3(1): 176-82.
 [http://dx.doi.org/10.1007/s42399-020-00696-0]

[102]
Sukmee T, Siripattanapipong S, Mungthin M, et al. A suspected new species of Leishmania, the causative agent of visceral leishmaniasis in a Thai patient. Int J Parasitol  2008; 38(6): 617-22.
 [http://dx.doi.org/10.1016/j.ijpara.2007.12.003] [PMID:  18262531]

[103]
Hotez PJ, Pecoul B. “Manifesto” for advancing the control and elimination of neglected tropical diseases. PLoS Negl Trop Dis  2010; 4(5): e718.
 [http://dx.doi.org/10.1371/journal.pntd.0000718] [PMID:  20520793]

[104]
Rosenzweig-Lipson S, Beyer CE, Hughes ZA, et al. Differentiating antidepressants of the future: Efficacy and safety. Pharmacol Ther  2007; 113(1): 134-53.
 [http://dx.doi.org/10.1016/j.pharmthera.2006.07.002] [PMID:  17010443]

[105]
Brambilla P, Perez J, Barale F, Schettini G, Soares JC. GABAergic dysfunction in mood disorders. Mol Psychiatry  2003; 8(8): 721-737, 715.
 [http://dx.doi.org/10.1038/sj.mp.4001362] [PMID: 12888801]

[106]
Sridharan S, Mohankumar K, Jeepipalli SPK, et al. Neuroprotective effect of Valeriana wallichii rhizome extract against the neurotoxin MPTP in C57BL/6 mice. Neurotoxicology  2015; 51: 172-83.
 [http://dx.doi.org/10.1016/j.neuro.2015.10.012] [PMID:  26522450]

[107]
Gilani AH, Bashir S, Memon R. Antispasmodic and antidiarrheal activities of valeriana hardwickii wall. Rhizome are putatively mediated through calcium channel blockade. Evid Based Complement Alter Med  2011; 2011: 304960.

[108]
Katzung BG, Masters SB, Trevor AJ. New York: McGraw Hill  2012.

[109]
Andreatini R, Sartori VA, Seabra MLV, Leite JR. Effect of valepotriates (valerian extract) in generalized anxiety disorder: A randomized placebo-controlled pilot study. Phyther Res  2002; 16(7): 650-4.

[110]
Kang W, Wilson SP, Wilson MA. Overexpression of proenkephalin in the amygdala potentiates the anxiolytic effects of benzodiazepines. Neuropsychopharmacology  2000; 22(1): 77-88.
 [http://dx.doi.org/10.1016/S0893-133X(99)00090-1] [PMID:  10633493]

[111]
Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol  2014; 4: 177.
 [http://dx.doi.org/10.3389/fphar.2013.00177] [PMID:  24454289]

[112]
Khare CP. Indian Medicinal Plants, An Illustrated Dictionary. Berlin, Heidelberg: Springer-Verlag 2007.
 [http://dx.doi.org/10.1007/978-0-387-70638-2]

[113]
Becker A, Felgentreff F, Schröder H, Meier B, Brattström A. The anxiolytic effects of a Valerian extract is based on valerenic acid. BMC Complement Altern Med  2014; 14(1): 267.
 [http://dx.doi.org/10.1186/1472-6882-14-267] [PMID:  25066015]

[114]
Limon A, Reyes-Ruiz JM, Miledi R. Loss of functional GABA(A) receptors in the Alzheimer diseased brain. Proc Natl Acad Sci USA  2012; 109(25): 10071-6.
 [http://dx.doi.org/10.1073/pnas.1204606109] [PMID:  22691495]

[115]
Carrasco MC, Vallejo JR, Pardo-de-Santayana M, Peral D, Martín MÁ, Altimiras J. Interactions of Valeriana officinalis L. and Passiflora incarnata L. in a patient treated with lorazepam.  Phyther Res  2009; 23(12): 1795-6.
 [http://dx.doi.org/10.1002/ptr.2847]

[116]
Khom S, Strommer B, Ramharter J, et al. Valerenic acid derivatives as novel subunit-selective GABAA receptor ligands - in vitro and in vivo characterization. Br J Pharmacol  2010; 161(1): 65-78.
 [http://dx.doi.org/10.1111/j.1476-5381.2010.00865.x] [PMID:  20718740]

[117]
Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch Pharmacol  2000; 362(4-5): 364-74.
 [http://dx.doi.org/10.1007/s002100000313] [PMID:  11111830]

[118]
Müller CE, Schumacher B, Brattström A, Abourashed EA, Koetter U. Interactions of valerian extracts and a fixed valerian-hop extract combination with adenosine receptors. Life Sci  2002; 71(16): 1939-49.
 [http://dx.doi.org/10.1016/S0024-3205(02)01964-1] [PMID:  12175708]

[119]
Schumacher B, Scholle S, Hölzl J, Khudeir N, Hess S, Müller CE. Lignans isolated from valerian: Identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptors. J Nat Prod  2002; 65(10): 1479-85.
 [http://dx.doi.org/10.1021/np010464q] [PMID:  12398547]

[120]
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin  2015; 65(2): 87-108.
 [http://dx.doi.org/10.3322/caac.21262] [PMID:  25651787]

[121]
Singh NK, Yadav AK, Sirohi P, et al. Anticancer activity of herbal medicine: Mechanism of action. In: Akhtar M, Swamy M, Eds. Anticancer Plants: Mechanisms and Molecular Interactions.  Singapore: Springer 2018; pp. 165-96.
 [http://dx.doi.org/10.1007/978-981-10-8417-1_7]

[122]
Zhang FF, Cudhea F, Shan Z, et al. Preventable cancer burden associated with poor diet in the United States. JNCI Cancer Spectr  2019; 3(2): pkz034.
 [http://dx.doi.org/10.1093/jncics/pkz034] [PMID:  31360907]

[123]
DeSantis CE, Miller KD, Dale W, et al. Cancer statistics for adults aged 85 years and older, 2019. CA Cancer J Clin  2019; 69(6): 452-67.
 [http://dx.doi.org/10.3322/caac.21577] [PMID:  31390062]

[124]
Siew YY, Yew HC, Neo SY, et al. Evaluation of anti-proliferative activity of medicinal plants used in Asian Traditional Medicine to treat cancer. J Ethnopharmacol  2019; 235: 75-87.
 [http://dx.doi.org/10.1016/j.jep.2018.12.040] [PMID:  30599223]

[125]
Tian S, Wang Z, Wu Z, Wei Y, Yang B, Lou S. Valtrate from Valeriana jatamansi Jones induces apoptosis and inhibits migration of human breast cancer cells in vitro. Nat Prod Res  2020; 34(18): 2660-3.
 [http://dx.doi.org/10.1080/14786419.2018.1548454] [PMID:  30638055]

[126]
Bhanot A, Sharma R, Noolvi MN. Natural sources as potential anti-cancer agents: A review. Int J Phytomed  2011; 3(1): 9-26.

[127]
Dorai T, Aggarwal BB. Role of chemopreventive agents in cancer therapy. Cancer Lett  2004; 215(2): 129-40.
 [http://dx.doi.org/10.1016/j.canlet.2004.07.013] [PMID:  15488631]

[128]
Srivastava DS, Vellend M. Biodiversity-ecosystem function research: Is it relevant to conservation? Annu Rev Ecol Evol Syst  2005; 36(1): 267-94.
 [http://dx.doi.org/10.1146/annurev.ecolsys.36.102003.152636]

[129]
Niles AL, Moravec RA, Riss TL. Update on in vitro cytotoxicity assays for drug development. Expert Opin Drug Discov  2008; 3(6): 655-69.
 [http://dx.doi.org/10.1517/17460441.3.6.655] [PMID:  23506147]

[130]
Horváth S. Cytotoxicity of drugs and diverse chemical agents to cell cultures. Toxicology  1980; 16(1): 59-66.
 [http://dx.doi.org/10.1016/0300-483X(80)90110-9] [PMID:  6996218]

[131]
McGaw LJ, Elgorashi EE, Eloff JN. Cytotoxicity of African medicinal plants against normal animal and human cells. In: Kuete V, Ed. Toxicological Survey of African Medicinal Plants.  Amsterdam, Netherlands: Elsevier 2014; pp. 181-233.
 [http://dx.doi.org/10.1016/B978-0-12-800018-2.00008-X]

[132]
Jain V, Dutta R, Maheshwari DT, Meena DK, Misra K, Sadashiva Yogendra Kumar M. Valeriana wallichii extract inhibits tert-BOOH induced oxidative damage and cytotoxicity. In: Front Biosci - Elit.  2018.

[133]
Keochanthala-Bounthanh C, Haag-Berrurier M, Beck JP, Anton R. Effects of thiol compounds versus the cytotoxicity of valepotriates on cultured hepatoma cells. Planta Med  1990; 56(2): 190-2.
 [http://dx.doi.org/10.1055/s-2006-960923] [PMID:  2353067]

[134]
Katoch O, Kaushik S, Kumar MS, Agrawala PK, Misra K. Radioprotective property of an aqueous extract from Valeriana wallichii. J Pharm Bioallied Sci  2012; 4(4): 327-32.
 [http://dx.doi.org/10.4103/0975-7406.103272] [PMID:  23248568]

[135]
Lin S, Fu P, Chen T, et al. Minor valepotriates from Valeriana jatamansi and their cytotoxicity against metastatic prostate cancer cells. Planta Med  2015; 81(1): 56-61.
 [PMID:  25469856]

[136]
Aydin F, Yurdakok Dikmen B, Kismali G. The potential cytotoxic effects of Valeriana officinalis extract on prostate cancer cell lines DU-145 and PC-3. Toxicol Lett  2016; 258: S299.
 [http://dx.doi.org/10.1016/j.toxlet.2016.06.2037]

[137]
Li X, Chen T, Lin S, et al. Valeriana jatamansi constituent IVHD-valtrate as a novel therapeutic agent to human ovarian cancer: In vitro and in vivo activities and mechanisms. Curr Cancer Drug Targets  2013; 13(4): 472-83.
 [http://dx.doi.org/10.2174/1568009611313040009] [PMID:  23597199]

[138]
Martinho A, Silva SM, Rosado T, et al. Valeriana spp.: Biological activities and new in vitro and in vivo perspectives. Curr Bioact Compd  2020; 16(3): 210-42.

[139]
Tortarolo M, Braun R, Hübner GE, Maurer HR. In vitro effects of epoxide-bearing alepotriates on mouse early hematopoietic progenitor cells and human T-lymphocytes. Arch Toxicol  1982; 51(1): 37-42.
 [http://dx.doi.org/10.1007/BF00279319]

[140]
Hayes AW, Kruger CL. Acute toxicity and eye irritancy. In: Hayes AW, Kruger CL, Eds. Hayes’ Principles and Methods of Toxicology.  London: CRC Press 2014; pp. 1117-72.

[141]
Barile FA. Validating and troubleshooting ocular in vitro toxicology tests. J Pharmacol Toxicol Methods  2010; 61(2): 136-45.
 [http://dx.doi.org/10.1016/j.vascn.2010.01.001] [PMID:  20096797]

[142]
Freshney RI. Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications.  (6th ed.), Hoboken, New Jersey: Wiley Online Library 2000.

[143]
Braca A, Sortino C, Politi M, Morelli I, Mendez J. Antioxidant activity of flavonoids from Licania licaniaeflora. J Ethnopharmacol  2002; 79(3): 379-81.
 [http://dx.doi.org/10.1016/S0378-8741(01)00413-5] [PMID:  11849846]

[144]
Yang HL, Chen CS, Chang WH, et al. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata. Cancer Lett  2006; 231(2): 215-27.
 [http://dx.doi.org/10.1016/j.canlet.2005.02.004] [PMID:  16399223]

[145]
HemaIswarya S. Doble M. Potential synergism of natural products in the treatment of cancer. Phytother Res  2006; 20(4): 239-49.
 [http://dx.doi.org/10.1002/ptr.1841] [PMID:  16557604]

[146]
de Araújo Júnior RF, de Souza TP, Pires JGL, et al. A dry extract of Phyllanthus niruri protects normal cells and induces apoptosis in human liver carcinoma cells. Exp Biol Med (Maywood)  2012; 237(11): 1281-8.
 [http://dx.doi.org/10.1258/ebm.2012.012130] [PMID:  23239439]

[147]
Taraphdar AK, Roy M, Bhattacharya RK. Natural products as inducers of apoptosis: Implication for cancer therapy and prevention. Curr Sci  2001; 80(11): 1387-96.

[148]
Moradpour D, Penin F, Rice CM. Replication of hepatitis C virus. Nat Rev Microbiol  2007; 5(6): 453-63.
 [http://dx.doi.org/10.1038/nrmicro1645] [PMID:  17487147]

[149]
Guha C, Lee SW, Chowdhury NR, Chowdhury JR. Cell culture models and animal models of viral hepatitis. Part II: Hepatitis C. Lab Anim  2005; 34: 39-47.

[150]
Munir S, Saleem S, Idrees M, et al. Hepatitis C treatment: Current and future perspectives. Virol J  2010; 7(1): 296.
 [http://dx.doi.org/10.1186/1743-422X-7-296] [PMID:  21040548]

[151]
Thomas DL. Global control of hepatitis C: Where challenge meets opportunity. Nat Med  2013; 19(7): 850-8.
 [http://dx.doi.org/10.1038/nm.3184] [PMID:  23836235]

[152]
Raimondi S, Bruno S, Mondelli MU, Maisonneuve P. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis. J Hepatol  2009; 50(6): 1142-54.
 [http://dx.doi.org/10.1016/j.jhep.2009.01.019] [PMID:  19395111]

[153]
Pawlotsky JM. New hepatitis C virus (HCV) drugs and the hope for a cure: Concepts in anti-HCV drug development. Semin Liver Dis  2014; 34(1): 22-9.
 [http://dx.doi.org/10.1055/s-0034-1371007] [PMID:  24782255]

[154]
Manns MP, von Hahn T. Novel therapies for hepatitis C - one pill fits all? Nat Rev Drug Discov  2013; 12(8): 595-610.
 [http://dx.doi.org/10.1038/nrd4050] [PMID:  23807378]

[155]
Yang PL, Gao M, Lin K, Liu Q, Villareal VA. Anti-HCV drugs in the pipeline. Curr Opin Virol  2011; 1(6): 607-16.
 [http://dx.doi.org/10.1016/j.coviro.2011.10.019] [PMID:  22440918]

[156]
Jardim ACG, Shimizu JF, Rahal P, Harris M. Plant-derived antivirals against hepatitis c virus infection. Virol J  2018; 15(1): 34.
 [http://dx.doi.org/10.1186/s12985-018-0945-3] [PMID:  29439720]

[157]
Ganta KK, Mandal A, Debnath S, Hazra B, Chaubey B. Anti-HCV activity from semi-purified methanolic root extracts of Valeriana wallichii.  Phyther Res  2017; 31(3): 433-40.

[158]
Kitamura M. The unfolded protein response triggered by environmental factors. Semin Immunopathol  2013; 35(3): 259-75.
 [http://dx.doi.org/10.1007/s00281-013-0371-y] [PMID:  23553212]

[159]
Bernales S, McDonald KL, Walter P. Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol  2006; 4(12): e423.
 [http://dx.doi.org/10.1371/journal.pbio.0040423] [PMID:  17132049]

[160]
Corazzari M, Gagliardi M, Fimia GM, Piacentini M. Endoplasmic reticulum stress, unfolded protein response, and cancer cell fate. Front Oncol  2017; 7: 78.
 [http://dx.doi.org/10.3389/fonc.2017.00078] [PMID:  28491820]

[161]
Hetz C. The unfolded protein response: Controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol  2012; 13(2): 89-102.
 [http://dx.doi.org/10.1038/nrm3270] [PMID:  22251901]

[162]
Huang CF, Liu SH, Su CC, et al. Roles of ERK/Akt signals in mitochondria-dependent and endoplasmic reticulum stress-triggered neuronal cell apoptosis induced by 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene, a major active metabolite of bisphenol A. Toxicology  2021; 455: 152764.
 [http://dx.doi.org/10.1016/j.tox.2021.152764] [PMID:  33771661]

[163]
Xu F, He B, Xiao F, et al. Neuroprotective effects of spinosin on recovery of learning and memory in a mouse model of Alzheimer’s disease. Biomol Ther (Seoul)  2019; 27(1): 71-7.
 [http://dx.doi.org/10.4062/biomolther.2018.051] [PMID:  29925225]

[164]
Bull VH, Thiede B. Proteome analysis of tunicamycin-induced ER stress. Electrophoresis  2012; 33(12): 1814-23.
 [http://dx.doi.org/10.1002/elps.201100565] [PMID:  22740470]

[165]
Xu J, Guo Y, Xie C, Jin DQ, Gao J, Gui L. Isolation and neuroprotective activities of acylated iridoids from Valeriana jatamansi. Chem Biodivers  2012; 9(7): 1382-8.
 [http://dx.doi.org/10.1002/cbdv.201100238] [PMID:  22782884]

[166]
Chakraborty S, Mukherjee D, Baskey S. Paradigm of demographic stochasticity-Way to extinction of Valeriana jatamansi Jones, a valuable Medicinal plant in North Eastern Himalayan Region. Ecol Environ Conserv  2015; 21(1): 521-8.

[167]
Kumari S, Krishna MJ, Joshi AB, et al. A pharmacognostic, phytochemical and pharmacological review of Terminalia bellerica. J Pharmacogn Phytochem  2017; 6(5): 368-76.

[168]
Boyadzhiev L, Kancheva D, Gourdon C, Metcheva D. Extraction of valerenic acids from valerian (Valeriana officinalis L.) rhizomes. Pharmazie  2004; 59(9): 727-8.
 [PMID:  15497760]

[169]
Wills RBH, Shohet D. Changes in valerenic acids content of valerian root (Valeriana officinalis L. s.l.) during long-term storage. Food Chem  2009; 115(1): 250-3.
 [http://dx.doi.org/10.1016/j.foodchem.2008.12.011]

[170]
Torkamani MRD, Jafari M, Abbaspour N, Heidary R, Safaie N. Enhanced production of valerenic acid in hairy root culture of Valeriana officinalis by elicitation. Cent Eur J Biol  2014; 9(9): 853-30.

[171]
Sonawane Akshay J, Shrikant T, Sherkar Mahesh R, Dhokane Sitaram T. Pharmacognostic account of roots of Valeriana wallichii DC. Int J Pharm Clin Res  2012; 4(4): 41-3.

[172]
Salimi A, Fatemi S, Nei Nei HZ, Safaralie A. Mathematical modeling of supercritical extraction of valerenic acid from Valeriana officinalis L. Chem Eng Technol  2008; 31(10): 1470-80.
 [http://dx.doi.org/10.1002/ceat.200800228]

[173]
Hromádková Z, Ebringerová A. Valachovič P. Ultrasound-assisted extraction of water-soluble polysaccharides from the roots of valerian (Valeriana officinalis L.). Ultrason Sonochem  2002; 9(1): 37-44.
 [http://dx.doi.org/10.1016/S1350-4177(01)00093-1] [PMID:  11602994]

[174]
Kobus Z. Dry matter extraction from valerian roots (Valeriana officinalis L.) with the help of pulsed acoustic field. Int Agrophys  2008; 22: 133-7.

[175]
Herrera-Arellano A, Luna-Villegas G, Cuevas-Uriostegui ML, et al. Polysomnographic evaluation of the hypnotic effect of Valeriana edulis standardized extract in patients suffering from insomnia. Planta Med  2001; 67(8): 695-9.
 [http://dx.doi.org/10.1055/s-2001-18344] [PMID:  11731907]

[176]
Keochanthala‐Bounthanh C, Beck JP, Haag‐Berrurier M, Anton R. Effects of two monoterpene esters, valtrate and didrovaltrate, isolated from Valeriana wallichii, on the ultrastructure of hepatoma cells in culture.  Phyther Res  1993; 7(2): 124-7.

[177]
Lin S, Fu P, Chen T, Ye J, Yang XW, Zhang WD. Three minor valepotriate isomers from Valeriana jatamansi and their cytotoxicity. J Asian Nat Prod Res  2017; 19(1): 15-21.
 [http://dx.doi.org/10.1080/10286020.2016.1258065] [PMID:  27924641]

[178]
de Oliveria DM, Barreto G, De Andrade DVG, et al. Cytoprotective effect of Valeriana officinalis extract on an in vitro experimental model of Parkinson disease. Neurochem Res  2009; 34(2): 215-20.
 [http://dx.doi.org/10.1007/s11064-008-9749-y] [PMID:  18512151]
Cite As
Current Traditional Medicine

A Review on Valeriana wallichii: Chemical Composition and Pharmacological Research

Abstract

Graphical Abstract
